Fabrazyme (agalsidase beta) Market, Global Outlook and Forecast 2022-2028

March 2022 | 72 pages | ID: F438CA6F496DEN
Market Monitor Global

Abstracts

Fabrazyme® (agalsidase beta) is used to treat patients with Fabry disease. Fabrazyme lowers the amount of a substance called globotriaosylceramide (GL-3), which builds up in cells lining the blood vessels of the kidney and certain other cells.

This report contains market size and forecasts of Fabrazyme (agalsidase beta) in global, including the following market information:

Global Fabrazyme (agalsidase beta) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Fabrazyme (agalsidase beta) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Fabrazyme (agalsidase beta) companies in 2021 (%)

The global Fabrazyme (agalsidase beta) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

5mg/vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Fabrazyme (agalsidase beta) include Genzyme Corporation. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fabrazyme (agalsidase beta) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Fabrazyme (agalsidase beta) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Fabrazyme (agalsidase beta) Market Segment Percentages, by Type, 2021 (%)

• 5mg/vial
• 35mg/vial

Global Fabrazyme (agalsidase beta) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Fabrazyme (agalsidase beta) Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Drug store

Global Fabrazyme (agalsidase beta) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Fabrazyme (agalsidase beta) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Fabrazyme (agalsidase beta) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Fabrazyme (agalsidase beta) revenues share in global market, 2021 (%)

Key companies Fabrazyme (agalsidase beta) sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Fabrazyme (agalsidase beta) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Genzyme Corporation

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Fabrazyme (agalsidase beta) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Fabrazyme (agalsidase beta) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FABRAZYME (AGALSIDASE BETA) OVERALL MARKET SIZE

2.1 Global Fabrazyme (agalsidase beta) Market Size: 2021 VS 2028
2.2 Global Fabrazyme (agalsidase beta) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Fabrazyme (agalsidase beta) Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Fabrazyme (agalsidase beta) Players in Global Market
3.2 Top Global Fabrazyme (agalsidase beta) Companies Ranked by Revenue
3.3 Global Fabrazyme (agalsidase beta) Revenue by Companies
3.4 Global Fabrazyme (agalsidase beta) Sales by Companies
3.5 Global Fabrazyme (agalsidase beta) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Fabrazyme (agalsidase beta) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Fabrazyme (agalsidase beta) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fabrazyme (agalsidase beta) Players in Global Market
  3.8.1 List of Global Tier 1 Fabrazyme (agalsidase beta) Companies
  3.8.2 List of Global Tier 2 and Tier 3 Fabrazyme (agalsidase beta) Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Fabrazyme (agalsidase beta) Market Size Markets, 2021 & 2028
  4.1.2 5mg/vial
  4.1.3 35mg/vial
4.2 By Type - Global Fabrazyme (agalsidase beta) Revenue & Forecasts
  4.2.1 By Type - Global Fabrazyme (agalsidase beta) Revenue, 2017-2022
  4.2.2 By Type - Global Fabrazyme (agalsidase beta) Revenue, 2023-2028
  4.2.3 By Type - Global Fabrazyme (agalsidase beta) Revenue Market Share, 2017-2028
4.3 By Type - Global Fabrazyme (agalsidase beta) Sales & Forecasts
  4.3.1 By Type - Global Fabrazyme (agalsidase beta) Sales, 2017-2022
  4.3.2 By Type - Global Fabrazyme (agalsidase beta) Sales, 2023-2028
  4.3.3 By Type - Global Fabrazyme (agalsidase beta) Sales Market Share, 2017-2028
4.4 By Type - Global Fabrazyme (agalsidase beta) Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Fabrazyme (agalsidase beta) Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Drug store
5.2 By Application - Global Fabrazyme (agalsidase beta) Revenue & Forecasts
  5.2.1 By Application - Global Fabrazyme (agalsidase beta) Revenue, 2017-2022
  5.2.2 By Application - Global Fabrazyme (agalsidase beta) Revenue, 2023-2028
  5.2.3 By Application - Global Fabrazyme (agalsidase beta) Revenue Market Share, 2017-2028
5.3 By Application - Global Fabrazyme (agalsidase beta) Sales & Forecasts
  5.3.1 By Application - Global Fabrazyme (agalsidase beta) Sales, 2017-2022
  5.3.2 By Application - Global Fabrazyme (agalsidase beta) Sales, 2023-2028
  5.3.3 By Application - Global Fabrazyme (agalsidase beta) Sales Market Share, 2017-2028
5.4 By Application - Global Fabrazyme (agalsidase beta) Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Fabrazyme (agalsidase beta) Market Size, 2021 & 2028
6.2 By Region - Global Fabrazyme (agalsidase beta) Revenue & Forecasts
  6.2.1 By Region - Global Fabrazyme (agalsidase beta) Revenue, 2017-2022
  6.2.2 By Region - Global Fabrazyme (agalsidase beta) Revenue, 2023-2028
  6.2.3 By Region - Global Fabrazyme (agalsidase beta) Revenue Market Share, 2017-2028
6.3 By Region - Global Fabrazyme (agalsidase beta) Sales & Forecasts
  6.3.1 By Region - Global Fabrazyme (agalsidase beta) Sales, 2017-2022
  6.3.2 By Region - Global Fabrazyme (agalsidase beta) Sales, 2023-2028
  6.3.3 By Region - Global Fabrazyme (agalsidase beta) Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Fabrazyme (agalsidase beta) Revenue, 2017-2028
  6.4.2 By Country - North America Fabrazyme (agalsidase beta) Sales, 2017-2028
  6.4.3 US Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.4.4 Canada Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.4.5 Mexico Fabrazyme (agalsidase beta) Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Fabrazyme (agalsidase beta) Revenue, 2017-2028
  6.5.2 By Country - Europe Fabrazyme (agalsidase beta) Sales, 2017-2028
  6.5.3 Germany Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.5.4 France Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.5.5 U.K. Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.5.6 Italy Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.5.7 Russia Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.5.8 Nordic Countries Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.5.9 Benelux Fabrazyme (agalsidase beta) Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Fabrazyme (agalsidase beta) Revenue, 2017-2028
  6.6.2 By Region - Asia Fabrazyme (agalsidase beta) Sales, 2017-2028
  6.6.3 China Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.6.4 Japan Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.6.5 South Korea Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.6.6 Southeast Asia Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.6.7 India Fabrazyme (agalsidase beta) Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Fabrazyme (agalsidase beta) Revenue, 2017-2028
  6.7.2 By Country - South America Fabrazyme (agalsidase beta) Sales, 2017-2028
  6.7.3 Brazil Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.7.4 Argentina Fabrazyme (agalsidase beta) Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Fabrazyme (agalsidase beta) Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Fabrazyme (agalsidase beta) Sales, 2017-2028
  6.8.3 Turkey Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.8.4 Israel Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.8.5 Saudi Arabia Fabrazyme (agalsidase beta) Market Size, 2017-2028
  6.8.6 UAE Fabrazyme (agalsidase beta) Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Genzyme Corporation
  7.1.1 Genzyme Corporation Corporate Summary
  7.1.2 Genzyme Corporation Business Overview
  7.1.3 Genzyme Corporation Fabrazyme (agalsidase beta) Major Product Offerings
  7.1.4 Genzyme Corporation Fabrazyme (agalsidase beta) Sales and Revenue in Global (2017-2022)
  7.1.5 Genzyme Corporation Key News

8 GLOBAL FABRAZYME (AGALSIDASE BETA) PRODUCTION CAPACITY, ANALYSIS

8.1 Global Fabrazyme (agalsidase beta) Production Capacity, 2017-2028
8.2 Fabrazyme (agalsidase beta) Production Capacity of Key Manufacturers in Global Market
8.3 Global Fabrazyme (agalsidase beta) Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 FABRAZYME (AGALSIDASE BETA) SUPPLY CHAIN ANALYSIS

10.1 Fabrazyme (agalsidase beta) Industry Value Chain
10.2 Fabrazyme (agalsidase beta) Upstream Market
10.3 Fabrazyme (agalsidase beta) Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Fabrazyme (agalsidase beta) Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Fabrazyme (agalsidase beta) in Global Market
Table 2. Top Fabrazyme (agalsidase beta) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Fabrazyme (agalsidase beta) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Fabrazyme (agalsidase beta) Revenue Share by Companies, 2017-2022
Table 5. Global Fabrazyme (agalsidase beta) Sales by Companies, (K Units), 2017-2022
Table 6. Global Fabrazyme (agalsidase beta) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Fabrazyme (agalsidase beta) Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Fabrazyme (agalsidase beta) Product Type
Table 9. List of Global Tier 1 Fabrazyme (agalsidase beta) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fabrazyme (agalsidase beta) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Fabrazyme (agalsidase beta) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Fabrazyme (agalsidase beta) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Fabrazyme (agalsidase beta) Sales (K Units), 2017-2022
Table 15. By Type - Global Fabrazyme (agalsidase beta) Sales (K Units), 2023-2028
Table 16. By Application – Global Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Fabrazyme (agalsidase beta) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Fabrazyme (agalsidase beta) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Fabrazyme (agalsidase beta) Sales (K Units), 2017-2022
Table 20. By Application - Global Fabrazyme (agalsidase beta) Sales (K Units), 2023-2028
Table 21. By Region – Global Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Fabrazyme (agalsidase beta) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Fabrazyme (agalsidase beta) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Fabrazyme (agalsidase beta) Sales (K Units), 2017-2022
Table 25. By Region - Global Fabrazyme (agalsidase beta) Sales (K Units), 2023-2028
Table 26. By Country - North America Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Fabrazyme (agalsidase beta) Sales, (K Units), 2017-2022
Table 29. By Country - North America Fabrazyme (agalsidase beta) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Fabrazyme (agalsidase beta) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Fabrazyme (agalsidase beta) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Fabrazyme (agalsidase beta) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Fabrazyme (agalsidase beta) Sales, (K Units), 2023-2028
Table 38. By Country - South America Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Fabrazyme (agalsidase beta) Sales, (K Units), 2017-2022
Table 41. By Country - South America Fabrazyme (agalsidase beta) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Fabrazyme (agalsidase beta) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Fabrazyme (agalsidase beta) Sales, (K Units), 2023-2028
Table 46. Genzyme Corporation Corporate Summary
Table 47. Genzyme Corporation Fabrazyme (agalsidase beta) Product Offerings
Table 48. Genzyme Corporation Fabrazyme (agalsidase beta) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Fabrazyme (agalsidase beta) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 50. Global Fabrazyme (agalsidase beta) Capacity Market Share of Key Manufacturers, 2020-2022
Table 51. Global Fabrazyme (agalsidase beta) Production by Region, 2017-2022 (K Units)
Table 52. Global Fabrazyme (agalsidase beta) Production by Region, 2023-2028 (K Units)
Table 53. Fabrazyme (agalsidase beta) Market Opportunities & Trends in Global Market
Table 54. Fabrazyme (agalsidase beta) Market Drivers in Global Market
Table 55. Fabrazyme (agalsidase beta) Market Restraints in Global Market
Table 56. Fabrazyme (agalsidase beta) Raw Materials
Table 57. Fabrazyme (agalsidase beta) Raw Materials Suppliers in Global Market
Table 58. Typical Fabrazyme (agalsidase beta) Downstream
Table 59. Fabrazyme (agalsidase beta) Downstream Clients in Global Market
Table 60. Fabrazyme (agalsidase beta) Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Fabrazyme (agalsidase beta) Segment by Type
Figure 2. Fabrazyme (agalsidase beta) Segment by Application
Figure 3. Global Fabrazyme (agalsidase beta) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Fabrazyme (agalsidase beta) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Fabrazyme (agalsidase beta) Revenue, 2017-2028 (US$, Mn)
Figure 7. Fabrazyme (agalsidase beta) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Fabrazyme (agalsidase beta) Revenue in 2021
Figure 9. By Type - Global Fabrazyme (agalsidase beta) Sales Market Share, 2017-2028
Figure 10. By Type - Global Fabrazyme (agalsidase beta) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Fabrazyme (agalsidase beta) Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Fabrazyme (agalsidase beta) Sales Market Share, 2017-2028
Figure 13. By Application - Global Fabrazyme (agalsidase beta) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Fabrazyme (agalsidase beta) Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Fabrazyme (agalsidase beta) Sales Market Share, 2017-2028
Figure 16. By Region - Global Fabrazyme (agalsidase beta) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Fabrazyme (agalsidase beta) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Fabrazyme (agalsidase beta) Sales Market Share, 2017-2028
Figure 19. US Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Fabrazyme (agalsidase beta) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Fabrazyme (agalsidase beta) Sales Market Share, 2017-2028
Figure 24. Germany Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 25. France Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Fabrazyme (agalsidase beta) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Fabrazyme (agalsidase beta) Sales Market Share, 2017-2028
Figure 33. China Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 37. India Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Fabrazyme (agalsidase beta) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Fabrazyme (agalsidase beta) Sales Market Share, 2017-2028
Figure 40. Brazil Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Fabrazyme (agalsidase beta) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Fabrazyme (agalsidase beta) Sales Market Share, 2017-2028
Figure 44. Turkey Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Fabrazyme (agalsidase beta) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Fabrazyme (agalsidase beta) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Fabrazyme (agalsidase beta) by Region, 2021 VS 2028
Figure 50. Fabrazyme (agalsidase beta) Industry Value Chain
Figure 51. Marketing Channels